Cancer centers launch research alliance

Share this article:

The Fred Hutchinson Cancer Research Center and Memorial Sloan-Kettering Cancer Center are working together to research ways to use patient immune systems to attack tumors. The Wall Street Journal reports that the alliance, which includes Seattle Children's Hospital—starts with “one of the largest first-round financings in 2013 among life-science companies.” The alliance—called Juno Therapeutics—launched Wednesday with $120 million in investments.

The Journal notes that the collaboration is an end to a silo'd approach to this same research, capping around two decades of individual research about how to turn immune systems against tumors. The Journal adds that the Hutchinson Center and Memorial Sloan-Kettering collaborated in a Stand Up to Cancer effort and that this interaction helped bring the new team approach into play.

Former Dendreon EVP/COO Hans Bishop is CEO of the new company.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Novartis said to be stepping out of HCV

Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.